SPARINGVISION

L'entreprise SPARINGVISION est spécialisée en recherches, études et analyses spécialisées.

Thierry Léveillard, PhD on Cellular and Molecular Biology, is Inserm Director or Research at Vision Institute (Paris) and head of Genetics Department. After several years of research in USA, in at UCSD and the Salk Institute and UCSC, he joined Genetics, Cellular and Molecular Biology Institute (IGBMC), then the Inserm laboratory at Strasbourg Louis Pasteur University. Author of several scientific reference publications in the field of genetics, he is co-founder, among other, of Rod derived Cone Viability Factor, the RdCVF. He has received numerous international awards, including the 1997 Neuronal Plasticity IPSEN Award, the 2005 Foundation Fighting Blindness (FFB) Trustee Award and the 2015 Prix de la fondation de l’oeil (Fondation de France). Thierry Léveillard is founder and, as scientific adviser for SparingVision, intervenes in all the phases of R and D regarding development of the viral vectors, in particular the realization of preclinical regulatory. Florence Allouche Ghrenassia, President Florence Allouche Ghrenassia is Pharmacist Doctor (Pharm D.), specialist in Intellectual property and tech transfer, Business developer, graduate from HEC Paris, she is Associate Professor at Paris Descartes University, for Innovation and Entrepreneurship, Chair dedicated to Innovation at the Faculty of Pharmacy of Paris. After positions in pharmaceutical industry, then in charge of R&D programs at Beckman Coulter, she created in 2000 the Office of Tech Transfer, Licensing & Industrial Ventures of Assistance Publique – Hôpitaux de Paris (OTT&PI) that she headed during 16 years.